Caption Management’s CATALENT, INC. CTLT Stock Holding History

Caption Management’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,400	Closed	-$1.49M	–	1583
2024 Q1	$1.49M	Buy	26,400 +13,400	+103%	+$726K	0.02%	628
2023 Q4	$584K	Sell	13,000 -59,000	-82%	-$2.39M	0.01%	920
2023 Q3	$3.28M	Buy	+72,000	New	+$3.36M	0.05%	450
2021 Q3	–	Sell	-23,300	Closed	-$2.52M	–	1861
2021 Q2	$2.52M	Buy	+23,300	New	+$2.5M	0.03%	597
2019 Q4	–	Sell	-5,210	Closed	-$248K	–	1023
2019 Q3	$248K	Sell	5,210 -39,790	-88%	-$2.14M	0.01%	569
2019 Q2	$2.44M	Buy	+45,000	New	+$2.06M	0.12%	218

Other funds holding CTLT

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EBA

Eagle Bay Advisors New York $134M AUM 30.07% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Caption Management's CTLT Position: Q2 2024 in Review

Caption Management sold out of CATALENT, INC. (CTLT) in Q2 2024, closing a stake of 26,400 shares — an estimated $1.49M sold.

Caption Management first reported a position in CTLT in Q2 2019 and held it in 6 quarters. The position peaked at $3.28M in Q3 2023. 448 funds tracked by Wall St. Rank hold CTLT as of Q2 2024.

Caption Management reported no remaining CATALENT, INC. position as of Q2 2024 after selling out during the quarter.
Caption Management sold 26,400 CATALENT, INC. shares in Q2 2024, an estimated $1.49M.
Caption Management first reported a position in CATALENT, INC. in Q2 2019 and held it in 6 quarters.
Caption Management's CATALENT, INC. position peaked at $3.28M in Q3 2023.
448 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.